102 related articles for article (PubMed ID: 7470410)
1. Epidemiological evidence for two components of cervical cancer.
Hakama M; Penttinen J
Br J Obstet Gynaecol; 1981 Mar; 88(3):209-14. PubMed ID: 7470410
[TBL] [Abstract][Full Text] [Related]
2. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
[TBL] [Abstract][Full Text] [Related]
3. Effect of population screening for carcinoma of the uterine cervix in Finland.
Hakama M
Maturitas; 1985 May; 7(1):3-10. PubMed ID: 4021826
[TBL] [Abstract][Full Text] [Related]
4. Experience of a continuing mass screening programme. Screening and re-screening for cervical carcinoma in Turku.
Grönroos M; Tyrkkö J; Järvi O; Rauramo L
Ann Chir Gynaecol Fenn; 1974; 63(6):470-8. PubMed ID: 4441027
[No Abstract] [Full Text] [Related]
5. Effect of a mass screening program on the risk of cervical cancer.
Hakama M; Räsänen-Virtanen U
Am J Epidemiol; 1976 May; 103(5):512-7. PubMed ID: 1274953
[TBL] [Abstract][Full Text] [Related]
6. Mass screenings for cervical cancer in Finland 1963-71. Organization, extent, and epidemiological implications.
Hakama M; Joutsenlahti U; Virtanen A; Räsänen-Virtanen U
Ann Clin Res; 1975 Apr; 7(2):101-11. PubMed ID: 1181974
[TBL] [Abstract][Full Text] [Related]
7. Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence.
Anttila A; Pukkala E; Söderman B; Kallio M; Nieminen P; Hakama M
Int J Cancer; 1999 Sep; 83(1):59-65. PubMed ID: 10449609
[TBL] [Abstract][Full Text] [Related]
8. Mass screening for cervical carcinoma in Finland. Organization and effect on morbidity and mortality.
Timonen S; Nieminen U; Kauraniemi T
Ann Chir Gynaecol Fenn; 1974; 63(2):104-12. PubMed ID: 4853102
[No Abstract] [Full Text] [Related]
9. Age-related incidence of cervical cancer supports two aetiological components: a population-based register study.
Seppä K; Pitkäniemi J; Malila N; Hakama M
BJOG; 2016 Apr; 123(5):772-8. PubMed ID: 26599730
[TBL] [Abstract][Full Text] [Related]
10. [Mass screening for cervical cancer in a high risk group].
Hakama M; Räsänen-Virtanen U
Duodecim; 1975; 91(9):579-85. PubMed ID: 1175484
[No Abstract] [Full Text] [Related]
11. Mass population screening for cervical cancer in Miyagi Prefecture.
Yajima A; Higashiiwai H; Sato A; Watanabe M; Hoshi K; Mori T; Yonemoto Y; Suzuki M; Noda K
Gynecol Oncol; 1979 Oct; 8(2):131-40. PubMed ID: 499921
[No Abstract] [Full Text] [Related]
12. Abnormal cervical smears: are we in for an epidemic?
Wolfendale MR; King S; Usherwood MM
Br Med J (Clin Res Ed); 1983 Aug; 287(6391):526-8. PubMed ID: 6411205
[TBL] [Abstract][Full Text] [Related]
13. Forty years of repeated screening: the significance of carcinoma in situ.
Morrison BJ; Coldman AJ; Boyes DA; Anderson GH
Br J Cancer; 1996 Sep; 74(5):814-9. PubMed ID: 8795587
[TBL] [Abstract][Full Text] [Related]
14. Mass screening in Sweden for cancer of the uterine cervix: effect on incidence and mortality. An overview.
Kjellgren O
Gynecol Obstet Invest; 1986; 22(2):57-63. PubMed ID: 3770533
[TBL] [Abstract][Full Text] [Related]
15. Risk of cervical cancer after a negative Pap smear.
Viikki M; Pukkala E; Hakama M
J Med Screen; 1999; 6(2):103-7. PubMed ID: 10444730
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer incidence and mortality trends in Finland and Estonia: a screened vs. an unscreened population.
Aareleid T; Pukkala E; Thomson H; Hakama M
Eur J Cancer; 1993; 29A(5):745-9. PubMed ID: 8471334
[TBL] [Abstract][Full Text] [Related]
17. Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears.
van Oortmarssen GJ; Habbema JD
Int J Epidemiol; 1995 Apr; 24(2):300-7. PubMed ID: 7635589
[TBL] [Abstract][Full Text] [Related]
18. Trends in cervical cancer and carcinoma in situ in Great Britain.
Cook GA; Draper GJ
Br J Cancer; 1984 Sep; 50(3):367-75. PubMed ID: 6466546
[TBL] [Abstract][Full Text] [Related]
19. [In situ and invasive cervical cancer epidemiology in the province of Girona, Spain 1990-2004: incidence, mortality, survival and screening history].
Castro Marqueta P; Moreno-Crespi J; Buxó-Pujolràs M; Cervantes-Amat M; Pérez-Gómez B; Marcos-Gragera R
Med Clin (Barc); 2011 Feb; 136(5):192-8. PubMed ID: 21051058
[TBL] [Abstract][Full Text] [Related]
20. Arkansas cervical cancer program.
Steinkamp RC; Roman-Lopez J; Kenney JA; Hairston MG; Hylton S; Hammett WN; Marsh S; Becton P; Collier S
J Ark Med Soc; 1980 Jan; 76(1):312-22. PubMed ID: 6444400
[No Abstract] [Full Text] [Related]
[Next] [New Search]
